Interview with Jimmy Sudharta, President and Founder, Mensa Group
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
Address: Jl. Raya Jakarta KM.28, jakarta,Indonesia
Tel: 62 21 3193 5822
Web: http://www.lifung.com/eng/global/home.php
The IDS Group is a member of the Li & Fung Group of companies. Headquartered in Hong Kong, the IDS Group provides a menu of Integrated-Distribution Services in three core businesses across Asia: Marketing, Logistics and Manufacturing, encompassing the full breadth and depth of the value chain.The IDS Group currently works with over 300 companies to bring their products to Asian consumers. Many of our clients are world admired multinational blue-chip brands. With an extensive logistics infrastructure and a staff force of over 5,000, our distribution network covers nine economies in the Greater China and Asean region covering the Mainland of China, Hong Kong, Taiwan, Thailand, Malaysia, Singapore, the Philippines, Indonesia and Brunei.The IDS Group sees distribution as more than just the sales and marketing of brands. We put a strong emphasis on Logistics as the fundamental enabler, connecting each of the core businesses. When Logistics is taken in its entirety with Marketing and Manufacturing, we see a connected Value-Chain across Asia. We call our unique proposition ‘Value-Chain Logistics’.
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
Many multinational companies have chosen to forgo establishing production facilities in Indonesia or have even shuttered their facilities, as did Janssen-Cilag. With the recent 10/10 decree, it seems the environment…
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes…
Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade?…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here
